MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Alterations in Gait Initiation of subjects with Parkinson’s Disease: a comparative study with matched healthy controls

D. Bonacina, D. Tosatto, A. Arrighetti, C. Perin, C. Alessandro, D. Piscitelli (Storrs, USA)

Meeting: 2025 International Congress

Keywords: Gait disorders: Clinical features, Parkinson’s, Rehabilitation

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: To compare spatiotemporal, kinetic and kinematic variables of Gait Initiation (GI) between individuals with Parkinson’s disease (PD) and healthy controls (HC).

Background: Balance and postural control impairments are cardinal symptoms of PD[1], affecting both walking and fall risk[ 2,3].Walking is an automatic task that begins with the volitional “first step”.GI involves transitioning from bipodal to single-leg support to execute the “first step”[4].Individuals with PD exhibit altered spatiotemporal parameters of the center of pressure (COP) during this transition[5],compared to healthy subjects which may impact kinetic and kinematic parameters of the “first step”.

Method: While standing on a force plate, participants began walking upon a visual cue. The first step was recorded on a second, contiguous force plate. Each subject performed three repetitions per leg, recorded using a motion capture system with 10 infra-red cameras (Qualisys). Continuous-time variables (Ground Reaction Forces-GRFs) were compared between groups using Statistical Parametric Mapping (MATLAB). The range of motion of lower limb joints at heel strike (discrete-time variable) and COP parameters (length, timing and velocity) were compared with t-test or U Mann-Withney depending on data distribution.

Results: Ten individuals with PD(age:60.6±7.3 years;H&Y:2) and ten matched HC(age:61.8±7.4 years) participated in the study. A significant increase in knee flexion (PD:12.3°±3.6vs. HC:8.0°±3.1; MD[Mean difference]:4.3°, p<0.001; 95%CI:-6.1 to -2.5) and ankle dorsiflexion (PD: 2.2°±5.8vs. HC: 0.03°±2.9; MD: 2.16°, p=0.01; 95%CI: -3.7 to -0.5) was observed in the PD group at heel contact of the first step. Regarding vertical GRF during the stance phase, the PD group exhibited a delayed passive first peak and a reduction in the subsequent active peak (p<0.05; Figure 1). Additionally, PD participants demonstrated reduced braking force and an early transition to a propulsive force, as indicated by antero-posterior GRF analysis (p<0.05; Figure 2). No other significant between-group differences were observed.

Conclusion: This study highlights differences in GI between individuals PD and HC, primarily in relation to GRFs which may serve as measures for assessing balance impairments in Parkinsonian gait. Further studies are needed to better understand their potential relationships with other kinetic and kinematic parameters.

Figure 1. Vertical GRF during stance phase

Figure 1. Vertical GRF during stance phase

Figure 2. Antero-posterior GRF during stance phase

Figure 2. Antero-posterior GRF during stance phase

References: 1) Kim SD, Allen NE, Canning CG, Fung VS. Postural instability in patients with Parkinson’s disease. Epidemiology, pathophysiology and management. CNS Drugs. 2013;27(2):97-112. doi:10.1007/s40263-012-0012-3
2) Mirelman A, Bonato P, Camicioli R, et al. Gait impairments in Parkinson’s disease. Lancet Neurol. 2019;18(7):697-708. doi:10.1016/S1474-4422(19)30044-4
3) Peterson DS, Horak FB. Neural Control of Walking in People with Parkinsonism. Physiology (Bethesda). 2016 Mar;31(2):95-107. doi: 10.1152/physiol.00034.2015. PMID: 26889015; PMCID: PMC4888974.
4) Martin M, Shinberg M, Kuchibhatla M, Ray L, Carollo JJ, Schenkman ML. Gait initiation in community-dwelling adults with Parkinson disease: comparison with older and younger adults without the disease. Phys Ther. 2002;82(6):566-577.
5) Palmisano C, Brandt G, Vissani M, Pozzi NG, Canessa A, Brumberg J, Marotta G, Volkmann J, Mazzoni A, Pezzoli G, Frigo CA, Isaias IU. Gait Initiation in Parkinson’s Disease: Impact of Dopamine Depletion and Initial Stance Condition. Front Bioeng Biotechnol. 2020 Mar 6;8:137. doi: 10.3389/fbioe.2020.00137. PMID: 32211390; PMCID: PMC7068722.

To cite this abstract in AMA style:

D. Bonacina, D. Tosatto, A. Arrighetti, C. Perin, C. Alessandro, D. Piscitelli. Alterations in Gait Initiation of subjects with Parkinson’s Disease: a comparative study with matched healthy controls [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/alterations-in-gait-initiation-of-subjects-with-parkinsons-disease-a-comparative-study-with-matched-healthy-controls/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/alterations-in-gait-initiation-of-subjects-with-parkinsons-disease-a-comparative-study-with-matched-healthy-controls/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley